Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024. Genpharmasec Rights Issue 2024 is listed on BSE while Skipper Rights Issue 2024 is listed on BSE, NSE.
| Genpharmasec Limited | Skipper Ltd | |
|---|---|---|
| Logo |  |
 |
| Listing At | BSE | BSE, NSE |
| Terms of Payment | Full amount of Rs.1.75 per Equity Share is payable on application. |
Issue Price of Rs.194 is to be paid as Rs. 48.50 on Application and Rs.145.50 on upto three Additonal Calls as may be decided by the Board/Rights Issue Committee. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 10 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  |
Application Form |
| Letter of Offer | Letter of Offer |
Letter of Offer |
| Registrar | Purva Sharegistry India Pvt Ltd | Maheshwari Datamatics Pvt. Ltd |
| Lead Managers | Vc Corporate Advisors Pvt Ltd (Vcapl) |
The issue size of Genpharmasec Rights Issue 2024 rights issue is ₹48.45 Crores, whereas Skipper Rights Issue 2024 rights issue size is ₹199.18 Crores.
| Genpharmasec Limited | Skipper Ltd | |
|---|---|---|
| Issue Size | 27,68,59,850 shares | 1,02,67,021 shares |
| Issue Size (Amount) | ₹48.45 Crores | ₹199.18 Crores |
| Issue Price | ₹1.75 per share | ₹194 per share |
| Face Value | ₹1 per share | ₹1 per share |
Find all the important dates related to the rights issue. The record date of Genpharmasec Rights Issue 2024 is Jan 09, 2024 while record date of Skipper Rights Issue 2024 is Jan 12, 2024.
| Genpharmasec Limited | Skipper Ltd | |
|---|---|---|
| Record Date | Jan 09, 2024 | Jan 12, 2024 |
| Credit of Rights Entitlements | ||
| Bid/Offer Opens On | Jan 23, 2024 | Jan 30, 2024 |
| Renunciation of Rights Entitlements | Feb 02, 2024 | Feb 05, 2024 |
| Bid/Offer Closes On | Feb 13, 2024 | Feb 08, 2024 |
| Deemed Date of Allotment | Feb 16, 2024 | Feb 15, 2024 |
| Credit Date | Feb 21, 2024 | Feb 16, 2024 |
| Listing Date | Feb 26, 2024 | Feb 19, 2024 |
Comparison of Genpharmasec Rights Issue 2024 and Skipper Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Genpharmasec Limited | Skipper Ltd | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Genpharmasec Limited Financial Information (Restated)Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Skipper Ltd Financial Information (Restated Consolidated)Skipper Ltd's revenue increased by 16.04% and profit after tax (PAT) rose by 41.43% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
